Contiguous Stage II Adult Diffuse Large Cell Lymphoma Terminated Phase 1 / 2 Trials for Fenretinide (DB05076)

IndicationStatusPhase
DBCOND0029466 (Contiguous Stage II Adult Diffuse Large Cell Lymphoma)Terminated1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00288067Fenretinide and Rituximab in Treating Patients With B-Cell Non-Hodgkin LymphomaTreatment